Safety and Efficacy Therapy of Gemcitabine and Erbitux® to R0 or R1 Resected Pancreatic Cancer
Clinical trial NCT00395252 · COMPLETED
Trial details
- NCT number
- NCT00395252
- Sponsor
- Carmen Schade-Brittinger
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2010-11-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.